Ngm biopharmaceuticals inc (NGM)
Income statement / Yearly
Dec'19Dec'18Dec'17
Related party revenue

103,544

108,665

77,141

Operating expenses:
Research and development

129,253

95,714

79,736

General and administrative

23,631

17,265

14,830

Total operating expenses

152,884

112,979

94,566

Loss from operations

-49,340

-4,314

-17,425

Interest income

6,692

3,622

2,358

Other income (expense), net

-147

199

-152

Net loss before taxes

-42,795

-493

-15,219

Benefit from income taxes

0

0

-1,060

Net loss

-42,795

-493

-14,159

Net loss per share, basic and diluted

-0.85

-0.08

-2.37

Weighted average shares used to compute net loss per share, basic and diluted

50,297

6,383

5,961